Benzodiazepine derivatives that inhibit rock
    4.
    发明授权
    Benzodiazepine derivatives that inhibit rock 失效
    抑制岩石的苯二氮卓衍生物

    公开(公告)号:US07888503B2

    公开(公告)日:2011-02-15

    申请号:US11577444

    申请日:2005-10-18

    IPC分类号: C07D243/14 A61K31/5513

    摘要: The present invention relates to dihydrobenzodiazepine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such dihydrobenzodiazepine derivatives are useful in the treatment of diseases associated with inappropriate ROCK kinase.

    摘要翻译: 本发明涉及二氢苯并二氮杂衍生物,含有它们的组合物和药物,以及这些化合物,组合物和药物的制备和用途的方法。 这样的二氢苯并二氮杂衍生物可用于治疗与不适当的ROCK激酶相关的疾病。

    CHEMICAL COMPOUNDS
    5.
    发明申请
    CHEMICAL COMPOUNDS 失效
    化学化合物

    公开(公告)号:US20090143366A1

    公开(公告)日:2009-06-04

    申请号:US11577444

    申请日:2005-10-18

    IPC分类号: A61K31/5513 C07D401/10

    摘要: The present invention relates to dihydrobenzodiazepine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such dihydrobenzodiazepine derivatives are useful in the treatment of diseases associated with inappropriate ROCK kinase.

    摘要翻译: 本发明涉及二氢苯并二氮杂衍生物,含有它们的组合物和药物,以及这些化合物,组合物和药物的制备和用途的方法。 这样的二氢苯并二氮杂衍生物可用于治疗与不适当的ROCK激酶相关的疾病。

    PYRIDOPYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USES AS ANTI-CANCER AND ANTI-DIABETE DRUGS
    6.
    发明申请
    PYRIDOPYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USES AS ANTI-CANCER AND ANTI-DIABETE DRUGS 审中-公开
    吡咯并吡嗪化合物及其作为抗癌剂和抗糖尿病药物的用途

    公开(公告)号:US20090054471A1

    公开(公告)日:2009-02-26

    申请号:US11815798

    申请日:2006-02-09

    IPC分类号: A61K31/519 C07D471/14

    CPC分类号: C07D471/14

    摘要: The present invention relates to pyridopyrazolopyrimidine derivatives that are useful pharmacological agents through the inhibition or antagonism of protein kinases, and to processes for the preparation and use of the same. In particular, the present invention relates to compounds that demonstrate protein tyrosine kinase and/or protein serine/threonine kinase inhibition.

    摘要翻译: 本发明涉及通过抑制或拮抗蛋白激酶而成为有用的药理学的吡哆吡唑并嘧啶衍生物及其制备和使用方法。 特别地,本发明涉及证明蛋白酪氨酸激酶和/或蛋白丝氨酸/苏氨酸激酶抑制的化合物。